Ann: Positive 6-Month Data from Cohort 1 in Phase 1 Trial in GvHD, page-36

Not sure we can read too much into todays very low vol. (dragonfly doji)

BUT, you'd expect interest to build into the Cohort B result due by end June and end of any EOFY adjustments.

Next WED is 28 days already. Big milestone...and as noted by a few here and MSB even, the 28 day is a very good indication of the 100 day...which Fuji will base option on.

game changer once we have a first commercial deal signed.
potentially and conservatively valued at a recurring A$40m pa at peak, if you look at MSBs recent broker report of a $1b market for GvHD (Japan/US) then Fuji are being conservative at US$300m market share imo.

Given recent comparisons and results, I am confident we have a more effective product in the making.